August 15, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced it has received a De Novo approval by the U.S. Food and Drug Administration (FDA) for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new regulatory category for cardiovascular machine learning-based notification software.

August 15, 2023 — There is new evidence that bolsters a possible link between e-cigarette use and increased risk of stroke, according to researchers from the University of Colorado Boulder. Their study conducted in humans showed that circulating endothelial cell-derived microvesicles (tiny, bubble-like particles released into the bloodstream during inflammation) from e-cigarette users have adverse effects on key factors responsible for regulating brain blood flow.

August 15, 2023  — Argus Cognitive, Inc., a digital health company that develops software medical devices, announced that it has been granted U.S. Food and Drug Administration (FDA) 510k clearance for its 3D echocardiography-based product.

August 14, 2023 — Patients often experience functional decline after an ischemic stroke, especially due to the brain’s resistance to regenerate after damage. Yet, there is still potential for recovery as surviving neurons can activate repair mechanisms to limit and even reverse the damage caused by the stroke. How is it triggered though?  

August 14, 2023 — Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled “Clinical trial updates on prevention and lipid lowering” at the 2023 ESC Congress taking place August 25-28, 2

August 14, 2023 — The FDA has announced that Datascope/Maquet/Getinge is recalling the Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) because they may shutdown unexpectedly due to electrical failures in the Power Management Board and/or Solenoid Board (Power Source Path). 

Using an affected pump may cause serious adverse health events, including unstable blood pressure, injury (for example: inadequate blood supply or a vital organ injury), and death. 

Speech Processing Solutions (SPS), a global leader in professional dictation solutions, is active in 50+ countries, with over 4 million users and a worldwide network of 1,000+ partners. It develops and markets industry-leading dictation and transcription solutions, automated documentation workflows with speech recognition, as well as award-winning dictation devices, sold under the Philips brand.

August 10, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a cardiac MRI solution provider announce a partnership to make the AI4CMR solution available on the Blackford Platform. AI4CMR will enable Blackford customers to automatically segment and quantify cardiac MRI measurements. 

August 10, 2023 — It is the position of SCAI that ABIM diplomates who successfully pass their exams and report procedural volumes in a timely fashion should be indisputably recognized as “certified” for the respecti

August 10, 2023 — Cardiovascular disease is the number one killer of all Americans. Yet, African Americans are 30% more likely to die from heart disease than non-Hispanic whites. 

Having high levels of low-density lipoprotein, or LDL (what some call "bad cholesterol"), is a well-known risk factor for cardiovascular disease, but a less-known risk may involve high levels of a particle called lipoprotein(a), also known as "Lp little a." 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now